GM, 3M, Novartis, Northrop Grumman, Hasbro, and D.R. Horton Beat Q2 Earnings Estimates

Earnings
โดย Zacks Investment Research·Read original
Summary · why it matters

Several major companies reported quarterly earnings beats on Tuesday morning. General Motors posted a 14% earnings surprise with $3.57 per share on revenues of $48.03 billion, and raised its full-year guidance. 3M delivered its biggest beat since the June quarter a year ago, with earnings of $2.40 per share topping estimates by 5.73%, and also raised its full-year outlook. Novartis reported a 9.55% beat with $2.41 per share, its first earnings beat since the December 2025 quarter. Northrop Grumman posted a 12.28% beat with $7.68 per share, its fifth straight beat, though shares fell 4.2% despite a record backlog of $105 billion. Hasbro beat estimates by 9.4% with $1.28 per share on revenues of $1.14 billion, up from $980.8 million a year ago. D.R. Horton reported a 7% beat with $3.20 per share on revenues of $9.23 billion, matching the year-ago tally.

Impact on stocks 6

Consumer Discretionary▲ · 2 stocks
DR Horton Inc
DHI
▲ PositiveCapitalrelevance

D.R. Horton reported a 7% earnings beat with $3.20 per share on revenues of $9.23 billion.

Hasbro Inc
HAS
▲ PositiveCapitalrelevance

Hasbro beat estimates by 9.4% with $1.28 per share on revenues of $1.14 billion, up from $980.8 million a year ago.

Electrification & Mobility▲ · 1 stocks
General Motors Company
GM
▲ PositiveCapitalrelevance

GM posted a 14% earnings surprise with $3.57 per share on revenues of $48.03 billion and raised full-year guidance.

Artificial Intelligence▲ · 1 stocks
3M Company
MMM
▲ PositiveCapitalrelevance

3M delivered its biggest beat since the June quarter a year ago, with earnings of $2.40 per share topping estimates by 5.73%, and raised full-year outlook.

Defense & Geopolitical Fragmentation▲ · 1 stocks
Northrop Grumman Corporation
NOC
± MixedCapitalrelevance

Northrop Grumman posted a 12.28% beat with $7.68 per share, its fifth straight beat, but shares fell 4.2% despite a record backlog of $105 billion.

Biotech & Genomic Medicine▲ · 1 stocks
Novartis AG
NOVN
▲ PositiveCapitalrelevance

Novartis reported a 9.55% earnings beat with $2.41 per share, its first beat since December 2025 quarter.

© 2026 MarketDXNews